Founded in 2000 and is headquartered in Tubingen, Germany
CureVac raised more than $213 million in its IPO. That is on top of the $640 million in financing the company raised in a private round that closed in July.
CVAC says its Phase 3 trial for a Covid-19 vaccine will publish results in Q4 2020 and the IPO enjoys strong investor support.
30% German Gov
Bill Gates
1) https://finviz.com/quote.ashx?t=cvac
What's your play for $CVAC??
*Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. Read More
Winkler Capital LLC, 100100 Overseas Hwy PO 370697 Key Largo, FL 33037-9998. This is for information purposes only as Winkler Capital LLC nor Alex Winkler is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting, or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation, or sponsorship of any company, security, or fund. Winkler Capital LLC and Alex Winkler cannot and does not assess, verify, or guarantee the adequacy, accuracy, or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Winkler Capital LLC and Alex Winkler in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Winkler Capital LLC and Alex Winkler accept no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.
